Character Biosciences, Inc.
JERSEY CITY, NJ · CIK 0002066192 · Biotech · Private
Genetic analysis and targeted therapies for age-related macular degeneration based on human genetics
characterbio.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $57M
- 2 Form D · Sep 2025
- 13 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 10
- 0 granted · 10 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $48,174,992 | |
| Private capital raised | Form D · SEC | $8,855,499 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2892 | OTHRO THERAPEUTICS, INC. | — | — |
| 2893 | Santa Ana Bio, Inc. | — | $63M |
| 2894 | General Specific Inc. | — | $1.5M |
| 2895 | Character Biosciences, Inc. | — | $57M |
| 2896 | ANAPTYSBIO INC | — | $51M |
| 2897 | Graywolf Therapeutics | — | — |
| 2898 | Beeline Medicines | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Mayssa AttarDirector
- Peter DiLauraDirector
- Vivek GaripalliDirector
- Jason HaflerDirector
- James KasuboskiDirector
- Nick OlsenDirector
- Reut ShemaDirector
- Cheng ZhangDirector · Executive Officer
Patents
- Methods Of Treating Ocular Diseases Using Engineered Polypeptides Comprising Complement Factor H And Factor H-like Protein Domainsapplication
- Compositions Comprising Factor H-like Protein Variants For Use In Treating Ocular Diseasesapplication
- Methods Of Treating Age-related Macular Degenerationapplication
- Compositions For Treatment Of Lipid Transport Dysfunctionapplication
- Therapeutic Compositions And Methods For Age-related Macular Degenerationapplication
- Therapeutic Lipid Processing Compositions And Methods For Treating Age-related Macular Degenerationapplication
- Therapeutic Compositions And Methods For Age-related Macular Degenerationapplication
- Therapeutic Lipid Processing Compositions And Methods For Treating Age-related Macular Degenerationapplication
- Therapeutic Compositions And Methods For Age-related Macular Degenerationapplication
- Therapeutic Lipid Processing Compositions And Methods For Treating Age-related Macular Degenerationapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.